4Mader R, Novofestovski I, Adawi M, et al. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis [ J ]. Semin Arthritis Rheum, 2009,38(5) :361-365.
5Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH) [J]. Osteoarthritis Cartilage, 2009,17(6) :825-828.
6Mader R, Buskila D, Verlaan J J, et al. Developing new classification criteria for diffuse idiopathic skeletal hyper- ostosis : back to square one[ J ]. Rheumatology (Oxford) , 2013,52(2) :326-330.
7Khan M A. HLA-B27 and its subtypes in world popula- tions [ J ]. Curr Opin Rheumatol, 1995,7 ( 4 ) : 263-269.
8Olivieri I, D3-ngelo S, Palazzi C, et al. Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondy- litis[J]. Curr Rheumatol Rep, 2009,11(5) :321-328.
9Freeston J, Barkham N, Hensor E, et al. Ankylosing spondytitis, HLA-B27 positivity and the need for biologic therapies [ J ]. Joint Bone Spine, 2007,74 (2) : 140-143.
